Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119272824 | 11927282 | 4 | F | 20160825 | 20160119 | 20160906 | EXP | GB-PFIZER INC-2016017072 | PFIZER | 82.00 | YR | F | Y | 80.00000 | KG | 20160906 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 119272824 | 11927282 | 1 | PS | CLINDAMYCIN HCL | CLINDAMYCIN HYDROCHLORIDE | 1 | 450 MG, 3X/DAY | U | 50162 | 450 | MG | CAPSULE, HARD | TID | ||||||
| 119272824 | 11927282 | 2 | I | ELIQUIS | APIXABAN | 1 | Oral | 2.5 MG, 1X/DAY | 0 | 2.5 | MG | FILM-COATED TABLET | QD | ||||||
| 119272824 | 11927282 | 3 | C | BISOPROLOL | BISOPROLOL | 1 | UNK | 0 | |||||||||||
| 119272824 | 11927282 | 4 | C | CANDESARTAN | CANDESARTAN | 1 | UNK | 0 | |||||||||||
| 119272824 | 11927282 | 5 | C | CARBOCISTEINE | CARBOCYSTEINE | 1 | UNK | 0 | |||||||||||
| 119272824 | 11927282 | 6 | C | CITALOPRAM | CITALOPRAM HYDROBROMIDE | 1 | UNK | 0 | |||||||||||
| 119272824 | 11927282 | 7 | C | DIGOXIN. | DIGOXIN | 1 | UNK | 0 | |||||||||||
| 119272824 | 11927282 | 8 | C | DIHYDROCODEINE | DIHYDROCODEINE | 1 | UNK | 0 | |||||||||||
| 119272824 | 11927282 | 9 | C | FUROSEMIDE. | FUROSEMIDE | 1 | UNK | 0 | |||||||||||
| 119272824 | 11927282 | 10 | C | HUMALOG MIX50/50 | INSULIN LISPRO | 1 | UNK | 0 | |||||||||||
| 119272824 | 11927282 | 11 | C | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | UNK | 0 | |||||||||||
| 119272824 | 11927282 | 12 | C | PARACETAMOL | ACETAMINOPHEN | 1 | UNK | 0 | |||||||||||
| 119272824 | 11927282 | 13 | C | PREMARIN | ESTROGENS, CONJUGATED | 1 | UNK | 0 | |||||||||||
| 119272824 | 11927282 | 14 | C | QUININE SULPHATE | QUININE SULFATE | 1 | UNK | 0 | |||||||||||
| 119272824 | 11927282 | 15 | C | TERBINAFINE. | TERBINAFINE | 1 | UNK | 0 | |||||||||||
| 119272824 | 11927282 | 16 | C | VITAMIN B12 | CYANOCOBALAMIN | 1 | UNK | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 119272824 | 11927282 | 1 | Osteomyelitis |
| 119272824 | 11927282 | 2 | Cerebrovascular accident prophylaxis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 119272824 | 11927282 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 119272824 | 11927282 | Abdominal wall haematoma | |
| 119272824 | 11927282 | Drug interaction | |
| 119272824 | 11927282 | Prescribed underdose |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |